Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104406256 | 10440625 | 6 | F | 20140414 | 20160708 | 20140909 | 20160712 | EXP | JP-JNJFOC-20140905599 | JANSSEN | 71.83 | YR | E | F | Y | 55.00000 | KG | 20160712 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104406256 | 10440625 | 1 | PS | SOVRIAD | SIMEPREVIR | 1 | Oral | N | 205123 | 100 | MG | CAPSULE | QD | ||||||
| 104406256 | 10440625 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 600 | MG | UNKNOWN | QD | ||||||
| 104406256 | 10440625 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 0 | 200 | MG | UNKNOWN | QD | ||||||
| 104406256 | 10440625 | 4 | SS | PEGASYS | PEGINTERFERON ALFA-2A | 1 | Subcutaneous | 0 | 180 | UG | INJECTION | /wk | |||||||
| 104406256 | 10440625 | 5 | C | NU-LOTAN | LOSARTAN POTASSIUM | 1 | Oral | 0 | 50 | MG | QD | ||||||||
| 104406256 | 10440625 | 6 | C | SODIUM RABEPRAZOLE | RABEPRAZOLE SODIUM | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 104406256 | 10440625 | 7 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | Oral | 0 | .5 | UG | QD | ||||||||
| 104406256 | 10440625 | 8 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 104406256 | 10440625 | 9 | C | BUP-4 | PROPIVERINE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 104406256 | 10440625 | 10 | C | NEUROVITAN | VITAMINS | 1 | Oral | 0 | 2 | DF | TABLET | QD | |||||||
| 104406256 | 10440625 | 11 | C | TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 1 | Oral | 0 | 400 | MG | UNSPECIFIED | QD | |||||||
| 104406256 | 10440625 | 12 | C | TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 1 | Oral | 0 | 100 | MG | UNSPECIFIED | QD | |||||||
| 104406256 | 10440625 | 13 | C | DEPAS | ETIZOLAM | 1 | Oral | 0 | 1 | MG | QD | ||||||||
| 104406256 | 10440625 | 14 | C | PROTECADIN | LAFUTIDINE | 1 | Oral | 0 | 20 | MG | UNSPECIFIED | QD | |||||||
| 104406256 | 10440625 | 15 | C | EPL | LECITHIN | 1 | Oral | 0 | 3 | DF | CAPSULE | QD | |||||||
| 104406256 | 10440625 | 16 | C | ALINAMIN F | FURSULTIAMINE HYDROCHLORIDE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 104406256 | 10440625 | 17 | C | URSO | URSODIOL | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 104406256 | 10440625 | 18 | C | MAGLAX | MAGNESIUM OXIDE | 1 | Oral | 0 | 990 | MG | QD | ||||||||
| 104406256 | 10440625 | 19 | C | ASPARA-CA | CALCIUM ASPARTATE | 1 | Oral | 0 | 400 | MG | UNKNOWN | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104406256 | 10440625 | 1 | Chronic hepatitis C |
| 104406256 | 10440625 | 2 | Chronic hepatitis C |
| 104406256 | 10440625 | 3 | Chronic hepatitis C |
| 104406256 | 10440625 | 4 | Chronic hepatitis C |
| 104406256 | 10440625 | 5 | Hypertension |
| 104406256 | 10440625 | 6 | Gastrooesophageal reflux disease |
| 104406256 | 10440625 | 7 | Osteoporosis |
| 104406256 | 10440625 | 8 | Hypertension |
| 104406256 | 10440625 | 9 | Pollakiuria |
| 104406256 | 10440625 | 13 | Insomnia |
| 104406256 | 10440625 | 14 | Gastrooesophageal reflux disease |
| 104406256 | 10440625 | 15 | Hepatic function abnormal |
| 104406256 | 10440625 | 17 | Hepatic function abnormal |
| 104406256 | 10440625 | 18 | Constipation |
| 104406256 | 10440625 | 19 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104406256 | 10440625 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104406256 | 10440625 | Anaemia | |
| 104406256 | 10440625 | Dysgeusia | |
| 104406256 | 10440625 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104406256 | 10440625 | 1 | 20140408 | 20140701 | 0 | |
| 104406256 | 10440625 | 2 | 20140408 | 20140429 | 0 | |
| 104406256 | 10440625 | 3 | 20140430 | 20141002 | 0 | |
| 104406256 | 10440625 | 4 | 20140408 | 20140924 | 0 |